Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 5/20 | 0.56 |
| ▸ | MMP3 | P08254 | 12/20 | 0.46 |
| ▸ | MMP1 | P03956 | 9/20 | 0.46 |
| ▸ | MMP2 | P08253 | 8/20 | 0.46 |
| ▸ | MMP7 | P09237 | 3/20 | 0.46 |
| ▸ | MMP9 | P14780 | 3/20 | 0.46 |
| ▸ | MMP14 | P50281 | 1/20 | 0.42 |
| ▸ | Q9HBH1 | 1/20 | 0.41 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Actinonin SCHEMBL279450 | 1.00 | BIRC2 (0.56) | BIRC2MMP3MMP1MMP2MMP7 | |
| Actinonin SCHEMBL279122 | 1.00 | BIRC2 (0.56) | BIRC2MMP3MMP1MMP2MMP7 | |
| Actinonin SCHEMBL14490676 | 1.00 | BIRC2 (0.56) | BIRC2MMP3MMP1MMP2MMP7 | |
| Actinonin SCHEMBL12601775 | 1.00 | BIRC2 (0.56) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL6294118 | 0.97 | BIRC2 (0.55) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL18328823 | 0.92 | MMP3 (0.49) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL21387112 | 0.92 | BIRC2 (0.47) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL14279424 | 0.90 | BIRC2 (0.55) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL6294172 | 0.87 | BIRC2 (0.58) | BIRC2MMP3MMP1MMP2MMP7 | |
| SCHEMBL9495973 | 0.87 | BIRC2 (0.44) | BIRC2MMP3MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2273 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151884-A1 | USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE | PARSONS C LOWELL (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025073942-A1 | MUSCLE STEM CELL CULTURE | UNIVERSITY OF HELSINKI (FI) | 2025-04-10 | — | — | WO | claimed |
| CN-119698270-A | Composition and method for producing the same | 阿马曾提斯公司 | 2025-03-25 | — | — | CN | claimed |
| EP-4496562-A1 | COMPOSITIONS | Amazentis SA (CH) | 2025-01-29 | — | — | EP | claimed |
| US-20240342175-A1 | Compositions and Methods for Treating Spinal Cord Injury and Synaptic Dysfunction | MITZ HOWARD (US) | 2024-10-17 | — | — | US | claimed |
| CN-118464557-A | Preparation method and evaluation method of docetaxel NLC delivery system | 吉林医药学院 | 2024-08-09 | — | — | CN | claimed |
| US-20240189317-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | ACADIA WOODS PARTNERS, LLC | 2024-06-13 | — | — | US | claimed |
| EP-4319877-A1 | COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURY AND SYNAPTIC DYSFUNCTION | Mitz, Howard (US) | 2024-02-14 | — | — | EP | claimed |
| EP-4308103-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | AI Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | claimed |
| US-20230413828-A1 | BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES | AGROSPHERES, INC. | 2023-12-28 | — | — | US | claimed |
| EP-0424193-B1 | Use of actinonin for the manufacture of a medicament for angiogenesis inhibition | ZAIDAN HOJIN BISEIBUTSU (JP) | 1994-01-12 | — | — | EP | claimed |
| EP-0296040-B1 | ACTINONIN DERIVATIVES HAVING PHYSIOLOGICAL ACTIVITIES | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1993-04-28 | — | — | EP | claimed |
| US-5206384-A | Enzyme inhibitors | ZAIDAN HOJIN BISEIBUTSU KAGAKU KAI (JP) | 1993-04-27 | — | — | US | claimed |
| US-5134156-A | Antiinflammatory agents or antidiabetic agents | ZAIDAN HOJIN BISEIBUTSU KAGAKU KAI (JP) | 1992-07-28 | — | — | US | claimed |
| EP-0474553-A1 | Actinonin derivatives | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1992-03-11 | — | — | EP | claimed |
| EP-0424193-A2 | Use of actinonin for the manufacture of a medicament for angiogenesis inhibition | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1991-04-24 | — | — | EP | claimed |
| US-4929633-A | ENZYME INHIBITORS, PEPTIDASES, ANTIAMNESIA AGENTS | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1990-05-29 | — | — | US | claimed |
| EP-0296040-A1 | Actinonin derivatives having physiological activities | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1988-12-21 | — | — | EP | claimed |
| US-4663342-A | ANTITUMOR | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1987-05-05 | — | — | US | claimed |
| EP-0167936-A2 | Use of actinonin as an immunopotentiator | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1986-01-15 | — | — | EP | claimed |